{"id":937213,"date":"2026-02-17T08:57:35","date_gmt":"2026-02-17T13:57:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/"},"modified":"2026-02-17T08:57:35","modified_gmt":"2026-02-17T13:57:35","slug":"fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/","title":{"rendered":"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services"},"content":{"rendered":"

\nAdds to executive focus on early clinical development and deepens medical and scientific partnership with clients
\n<\/h2>\n
\n

DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) — Fortrea<\/u><\/a> (Nasdaq: FTRE) (the \u201cCompany\u201d), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who previously served as both Fortrea\u2019s chief medical officer (CMO) and president of Clinical Pharmacology Services (CPS) is now dedicated to his CMO responsibilities, namely medical strategy, scientific leadership, ethics and governance oversight across Fortrea\u2019s portfolio. Scott Dove, PhD joins Fortrea as its new president of CPS, responsible for Fortrea\u2019s early clinical development solutions across its global network of clinical research units. Cohen and Dove both serve on Fortrea\u2019s Executive Committee.<\/p>\n

\u201cThe addition of Scott to the Fortrea team while Oren becomes fully dedicated to the medical and scientific aspects of development is a win for clients,\u201d said Anshul Thakral, CEO. \u201cWorking closely with our business leaders across all phases of clinical development, Oren will deepen his relationships with clients. He\u2019s engaging earlier in scientific dialogue and collaborating closely with our physicians and therapeutic leaders to help address complex development challenges, all while upholding the highest standards of scientific integrity and patient safety. Scott is making a fast start with our Clinical Pharmacology team and is getting a first-hand view of our world-class clinics. He combines a strong technical background in clinical development and operations with a successful track record of leadership in building and leading global organizations, and I\u2019m looking forward to his insights on how we further strengthen our offering.\u201d<\/p>\n

\n Oren Cohen, MD Chief Medical Officer<\/strong>\n <\/p>\n

Oren Cohen, MD is a veteran of drug development, bringing more than 20 years of experience in various medical and scientific executive leadership roles in the pharmaceutical industry. Prior to Fortrea, Dr. Cohen served as CMO and head of Clinical Pharmacology Services at Labcorp Drug Development. Previously, he was CMO at Viamet Pharmaceuticals and served in several senior medical and operational leadership positions at Quintiles, now part of IQVIA.<\/p>\n

Dr. Cohen received his MD from Duke University and served his internship and residency at The New York Hospital, Cornell Medical Center in New York City. He completed his fellowship in Infectious Diseases at the National Institute of Allergy and Infectious Diseases, where he stayed as a Principal Investigator and served as the institute’s assistant director for medical affairs. He is a Consulting Professor of Medicine at Duke University Medical Center, a member of the Board of Visitors for Duke University School of Medicine and a Fellow of the Infectious Diseases Society of America.<\/p>\n

\n Scott Dove, PhD President Clinical Pharmacology Services <\/strong>\n <\/p>\n

Scott Dove, PhD brings more than 25 years of drug development experience to Fortrea, serving in roles of increasing responsibility at pharma, biotech and CRO companies. Most recently, he has served as an advisor to a variety of companies, including Fortrea. Previously, Dr. Dove was chief operating officer at Aravive, leading R&D operations for a clinical stage, oncology-focused biotech.\u00a0He also served in leadership roles at PPD for more than a decade, where he led early development services. Dr. Dove also held leadership roles at Allergan and Furiex Pharmaceuticals.<\/p>\n

Dr. Dove received his PhD from Texas A&M Health Science Center and earned his bachelor of science in biochemistry at Texas A&M University.<\/p>\n

\n About Fortrea<\/strong>\n <\/p>\n

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea\u2019s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at\u00a0Fortrea.com<\/a>\u00a0and follow us on\u00a0LinkedIn<\/a>\u00a0and\u00a0X<\/a>\u00a0(formerly Twitter).\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n

\n Fortrea Contacts:<\/strong>
\n
Tracy Krumme (Investors) \u2013 984-385-6707, Tracy.Krumme@fortrea.com<\/a>
Sue Zaranek (Media) \u2013 919-943-5422, media@fortrea.com<\/a>
Kate Dillon (Media) \u2013 646-818-9115, kdillon@prosek.com<\/a>
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Adds to executive focus on early clinical development and deepens medical and scientific partnership with clients DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the \u201cCompany\u201d), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who previously served as both Fortrea\u2019s chief medical officer (CMO) and president of Clinical Pharmacology Services (CPS) is now dedicated to his CMO responsibilities, namely medical strategy, scientific leadership, ethics and governance oversight across Fortrea\u2019s portfolio. Scott Dove, PhD joins Fortrea as its new president of CPS, responsible for Fortrea\u2019s early clinical development solutions across its global network of clinical research units. Cohen and Dove both serve on Fortrea\u2019s Executive Committee. \u201cThe addition … <\/p>\n

Continue reading “Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-937213","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Adds to executive focus on early clinical development and deepens medical and scientific partnership with clients DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the \u201cCompany\u201d), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who previously served as both Fortrea\u2019s chief medical officer (CMO) and president of Clinical Pharmacology Services (CPS) is now dedicated to his CMO responsibilities, namely medical strategy, scientific leadership, ethics and governance oversight across Fortrea\u2019s portfolio. Scott Dove, PhD joins Fortrea as its new president of CPS, responsible for Fortrea\u2019s early clinical development solutions across its global network of clinical research units. Cohen and Dove both serve on Fortrea\u2019s Executive Committee. \u201cThe addition … Continue reading "Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-17T13:57:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services\",\"datePublished\":\"2026-02-17T13:57:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/\"},\"wordCount\":730,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/\",\"name\":\"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=\",\"datePublished\":\"2026-02-17T13:57:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/","og_locale":"en_US","og_type":"article","og_title":"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - Market Newsdesk","og_description":"Adds to executive focus on early clinical development and deepens medical and scientific partnership with clients DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the \u201cCompany\u201d), a leading global contract research organization (CRO), today announced it has expanded its executive team. Oren Cohen, MD who previously served as both Fortrea\u2019s chief medical officer (CMO) and president of Clinical Pharmacology Services (CPS) is now dedicated to his CMO responsibilities, namely medical strategy, scientific leadership, ethics and governance oversight across Fortrea\u2019s portfolio. Scott Dove, PhD joins Fortrea as its new president of CPS, responsible for Fortrea\u2019s early clinical development solutions across its global network of clinical research units. Cohen and Dove both serve on Fortrea\u2019s Executive Committee. \u201cThe addition … Continue reading \"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-17T13:57:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services","datePublished":"2026-02-17T13:57:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/"},"wordCount":730,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/","name":"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=","datePublished":"2026-02-17T13:57:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1NTM4MyM3NDI2MzM3IzIyNTgxMjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortrea-expands-executive-team-appointing-oren-cohen-as-chief-medical-officer-and-scott-dove-as-president-of-clinical-pharmacology-services\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/937213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=937213"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/937213\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=937213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=937213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=937213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}